Opportunity Knocks: FDA/CDRH Medical Device Fellowship and External Expertise

Similar documents
Pediatric Drug Development: Successes and Challenges

Global Pediatric Development: We Are Making Progress. PMDA Perspective. Junko Sato, PhD PMDA

GDUFA: 2 ½ years later Impact & Importance

HIV and Drug Use Research Fellowship. Programme and Application Webinar

Introduction and Workshop Objectives

Responsibilities of Laser Light Show Projector Manufacturers, Dealers, and Distributors; Final Guidance for Industry and FDA.

Naloxone Expanded Access: OTC status Considerations for a Nonprescription Drug Development Program

COMMENTS. Submitted by The International Pharmaceutical Aerosol Consortium

REVIEW MANAGEMENT. Clinical Review of Drugs to Reduce the Risk of Cancer CONTENTS

Committed to Environment, Health, & Safety

Strategic Operational Research Plan February 13, Scientific Office Digestive Health Strategic Clinical Network

QUESTIONS & ANSWERS: PRACTISING DENTAL HYGIENISTS and STUDENTS

The European Board of Urology

Background. Historical Context

Consultant Services to Kansas Family Physicians

Scope of Practice for the Diagnostic Ultrasound Professional

Generic Drug User Fee Amendments of 2012; Regulatory Science Initiatives; Public Hearing;

The Reprocessing of Single- Use Medical Devices; Regulations Coming to Europe? CleanMed Europe Malmo, Sweden 26 September 2012

INTERNATIONAL NUCLEAR SAFEGUARDS ENGAGEMENT PROGRAM. National Nuclear Security Administration. Nuclear Safeguards

Application of Bayesian Extrapolation in Pediatric Drug Development Program

5.I.1. GENERAL PRACTITIONER ANNOUNCEMENT OF CREDENTIALS IN NON-SPECIALTY INTEREST AREAS

Clinical Endpoint Bioequivalence Study Review in ANDA Submissions. Ying Fan, Ph.D.

Use of Standards in Substantial Equivalence Determinations

Medpace, a pioneer in the development of therapeutics to treat metabolic disorders, is your first stop for compound development in lipid studies.

By Laws: Spinal Cord Injury Research Fund Board Board Approval May 2, 2014

Mercy Health Corporation (WI)

SullivanCotter 2012 Physician Compensation and Productivity Survey

5 American Journal of Kidney Diseases Elsevier NEPHROLOGY Science Direct

Class II Special Controls Guidance Document: Intraoral Devices for Snoring and/or Obstructive Sleep Apnea; Guidance for Industry and FDA

Integration of Specialty Care into ACOs: Considering JMAP and Beyond

AAP Immunization Initiatives JILL HERNANDEZ, MPH

Regulatory interactions: Expectations on extrapolation approaches

Using and Referencing ISO and IEC Standards for Technical Regulation

Basic Standards for Fellowship Training in Sleep Medicine

I-1 TIME SERIES - MOST RECENT FIVE YEARS Field of post-m.d. training and source of funding

Curriculum Vitae. EDUCATION M.S. Biomedical Engineering, University of Alabama Birmingham (1992) B.S. Biomedical Engineering, Tulane University (1989)

Introduction. Current status of 510(k) clinical data requirements. 1 Current Status&Considerations:

Council of Pediatric Subspecialties: CoPS April Jim Bale, MD Chair, CoPS

PMDA Considerations for Outcome Assessments

NASH Regulatory Landscape. Veronica Miller, PhD Forum for Collaborative Research UC Berkeley SPH

Agenda: Dental Cone Beam Imaging

Sterility Assurance and Risk Management: A CDER Microbiologist s Perspective

Annual Review of Pathology: Mechanisms of Disease Annual Review Pathology 2011-till date

Comprehensive Cancer Control Technical Assistance Training and Communication Plan. PI: Mandi Pratt-Chapman, MA. Cooperative Agreement #1U38DP

Obesity Medicine: Building Credibility and Seeking Certification in a Stigmatized Field

ADNI Experience on Developing Biomarker Tools as Example of An Approach to Catalyzing Dry AMD Drug Development

Letter to the AMGA Board of Directors...1 Introduction...3

Basic Standards for Osteopathic Fellowship Training in Sleep Medicine

Table 1 ABMS MEMBER BOARDS APPROVED GENERAL CERTIFICATES

NIH Initiatives in Nutrition: Roadmap, Strategic Plan

Tuberous Sclerosis Complex Research Program

Clinical Chemistry and Clinical Toxicology Devices Panel of the Medical Devices Advisory

Better Partner Health

Charlie Norwood VA Medical Center. Robert U. Hamilton, FACHE Medical Center Director

Specialty-specific References for DIOs: Expected Time for Coordinator

Appendix A Residents and Fellows Cardiopulmonary Resuscitation (CPR) Certification Requirements by Program

September 20, Thomas Scully Administrator Centers for Medicare and Medicaid Services 200 Independence Avenue SW Washington, DC 20201

Straub Clinic and Hospital Implementation Strategy Plan. May 2013

The Telemetric and Holter ECG Warehouse (THEW) Initiative

Association of American Cancer Institutes

The EU PIP - a step in Pediatric Drug Development. Thomas Severin Bonn,

Specific Standards of Accreditation for Residency Programs in Adult and Pediatric Neurology

Ovid-Lippincott Journals

ANESTHESIOLOGY Comments:

BD-STEP: Tackling Key Issues Across Cancer Research and Care

The Challenge of Treating Pain

1 of 9 6/25/17 1:22 AM

CDRH: 510(k)S AND SCIENCE IN REGULATOR DECISION-MAKING. lannery, Scott Danzis and Christopher Pruitt. November 2010 SPECIAL REPRINT

Draft Guidance for Industry and FDA Staff

AVMED SPECIALIST/SPECIALTIES REQUIRING MEDICARE REFERRAL

MIAMI CHILDREN S HOSPITAL POLICY AND PROCEDURE

SPECIALTY CPT CODES DESCRIPTION

Letter to the AMGA Board of Directors...1 Introduction...3

Re: Docket No. FDA D Presenting Risk Information in Prescription Drug and Medical Device Promotion

NOTICE OF INITIATION OF DISQUALIFICATION PROCEEDINGS AND OPPORTUNITY TO EXPLAIN

Collaboration with Cairo University. Cairo University, Faculty of Medicine

Successful collaboration for research development between the NIH and patient organisations

Food Labeling: Policy Rationale IFT Food Policy Impact, 2011

Emergency Use Authorizations

Children s Hospital of Philadelphia Committees for the Protection of Human Subjects Policies and Procedures Research That Must Be Reviewed by the IRB

2018 Via Hope Peer Services Implementation Learning Community Application Supplement

National Comprehensive Cancer Control Program Reviewer Training March 16, 2017

Purpose of this Document

Number of Accredited Programs

Letter to the AMGA Board of Directors... 1 Introduction... 3

Regulatory scientific significance of Japan s ADR relief system

Comments of the Patient, Consumer, and Public Health Coalition. Strengthening the Center for Devices and Radiological Health s 510(k) Review Process

A Purchaser s Guide to Clinical Preventive Services: Moving Science into Coverage

Neurosurgical Technology and Treatment Techniques

The MGH Journey. Shaping the Future of an Entire Region

International Pharmaceutical Aerosol Consortium on Regulation and Science

FELLOWSHIP in CEREBROVASCULAR SURGERY and SKULL BASE SURGERY

GUIDELINES FOR SUPERVISION, ROLES, AND RESPONSIBILITIES DURING THE DELIVERY OF OCCUPATIONAL THERAPY SERVICES

Letter to the AMGA Board of Directors... 1 Introduction... 3

Apostolic Faith Mission of South-Africa Pastors Continuous Development.

Overhauling The 510(k) Process

HEALTH ACCESS NETWORK

Mayo Clinic Gynecologic Oncology Fellowship (Minnesota) Competency-based goals

Date January 20, Contact Information

Transcription:

Opportunity Knocks: FDA/CDRH Medical Device Fellowship and External Expertise Nancy J. Pluhowski Director, Office of the Center Director Center for Devices and Radiological Health (CDRH), FDA Stanford University A Total Product Lifecycle Approach to Medical Device Development: Responsibilities and Opportunities September 2010

Disclaimer This communication does not constitute a written advisory opinion under 21 CFR 10.85, but rather is an informal communication under 21 CFR 10.85(k) which represents the best judgment of the employee providing it. This information does not necessarily represent the formal position of FDA, and does not bind or otherwise obligate or commit the agency to the views expressed. September, 2010 2

CDRH (EEP): What We Do in EEP EEP provides guidance and assistance to CDRH to: Identify the needs for expertise within CDRH Foster collaborations with experts in the medical community and academic institutions to fulfill expertise needs Establish technology transfer agreements to develop and formalize partnerships Administer the Critical Path Program within CDRH September, 2010 3

Outline for Presentation Fellowship Programs CDRH s Medical Device Fellowship Program (MDFP) FDA Commissioner s Fellowship Program (CFP) FDA s Critical Path Program September, 2010 4

Medical Device Fellowship Program (MDFP) EEP uses MDFP to expand CDRH s capacity to obtain the expertise required to regulate medical devices of ever-increasing complexity September, 2010 5

Expertise at CDRH acquired through MDFP includes: Cardiothoracic Surgery Interventional Cardiology Electrophysiology Neurosurgery Pulmonology Gastroenterology Ophthalmology Internal Medicine Nephrology Plastic Surgery Psychiatry Orthopedic Surgery Obstetrician and Gynecology Biomedical Engineering Biology Chemistry Epidemiology Biostatistics Regulatory Law September, 2010 6

Academic Institutions Fellows have come to CDRH from: Stanford University Harvard University Johns Hopkins University Cleveland Clinic University of Pittsburgh George Washington University University of Texas Health Sciences Center William and Mary Mayo Clinic University of North Carolina Syracuse University University of Maryland September, 2010 7

MDFP Fellows from Stanford Univ. Project examples: Computational modeling for cardiovascular devices Applying regulatory device processes to dental amalgam MDFP Intern Projects September, 2010 8

MDFP Fellows from Stanford Univ. Computational Modeling for Cardiovascular Devices CDRH in collaboration with Stanford, NHLBI, and NSF held a Critical Path Workshop on Use of Computational Modeling Techniques for Cardiovascular Device Development which identified the current challenges for this important area of cardiovascular medical device development September, 2010 9

MDFP Fellows from Stanford Univ. Apply Regulatory Processes to Dental Amalgam Research and analyze comments from a 2002 proposed rule on dental amalgam Review and summarize comments from a 2008 Federal Register Notice of final rule on dental amalgam Serve as a medical device reviewer in the Dental Devices Branch September, 2010 10

MDFP Fellows from Stanford Univ. Intern Project (example) Analyze adverse reports in the MAUDE database to help identify any specific issues related to the use of surgical mesh. The data will be analyzed for trends to determine patterns in specific product characteristics or categories that contribute significantly to adverse events September, 2010 11

MDFP Fellows from Stanford Univ. Intern Project (example) Analyze adverse event data of MRI related thermal injuries, develop a scientific rationale for the occurrences, and determine suitable preventative measures September, 2010 12

MDFP Fellows from Stanford Univ. Intern Project (example) Evaluate partnership opportunities in EEP and develop collaboration policy statements to help support public health initiatives Collect and analyze data from sources associated with each area of EEP - Critical Path, MDFP and Tech Transfer September, 2010 13

Commissioner s Fellowship Program at FDA Engineering Candidates may have BS, MS, PhD or but all other candidates must have MD or PhD level Combination of project and required course work All fellows start as a cohort in October of each year Application period is January to March Website - go to www.fda.gov, find this link: http://www.fda.gov/aboutfda/workingatfda/fellowshipinternshipgrad uatefacultyprograms/commissionersfellowshipprogram/default.htm Or, search www.fda.gov for CDRH preceptors to find a list of CDRH preceptors September, 2010 14

Critical Path (CP) Program The goal of FDA s Critical Path Program is to identify and prioritize the most pressing problems in medical product development and the greatest opportunities for improvement in public health benefits Critical Path Opportunities Report http://www.fda.gov/oc/initiatives/critical path/ September, 2010 15

Examples of CDRH CP Projects Leverage the Simulation-Based Engineering and Medical Imaging Technology GOAL: Promote the use of computational modeling in cardiovascular device design and address barriers and regulatory issues needed to implement modeling September, 2010 16

Examples of CDRH CP Projects Conduct research to ultimately standardize CT Protocols for Imaging-based Measures of Disease Status in Lung Cancer GOAL: Improved use of CT for evaluating effect of therapy and drug trials for lung cancer September, 2010 17

Examples of CDRH CP Projects Biomarkers of Acute Kidney Injury to Improve Public Health and Product Approval GOAL: Development of new biomarkers to detect acute kidney injury previous biomarkers detected damage when injury was severe September, 2010 18

Examples of CDRH CP Projects Standardize Assessment of Impingement in Spinal Devices GOAL: Develop and validate impingement testing to better predict device success September, 2010 19

Thank you! External Expertise and Partnerships nancy.pluhowski@fda.hhs.gov 301.796.5696 Technology Transfer v.michelle.chenault@fda.hhs.gov 301.796.5679 Medical Device Fellowship Program jackie.czecha@fda.hhs.gov 301.796.5682 Critical Path Initiative anindita.saha@fda.hhs.gov 301.796.2537 20